Welcome to the e-CCO Library!

P475: Gastroenterological and reumatological chronic patients: are there differences in individual welfare and quality of life?—a cross-observational study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Stefani, M. G. Vettorato*, G. Lorenzon, T. Marcon, F. Simonetti, A. Rigo, E. V. Savarino, E. De Marchi, R. D’Incà, G. C. Sturniolo

Created: Friday, 22 February 2019, 9:49 AM
P475: High prevalence of severe liver fibrosis in patients with longstanding IBD
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Steenhuis, S. Van der Marel*, A. Van der Meulen- de Jong, J. Maljaars

Created: Thursday, 21 February 2019, 9:14 AM
P475: Infections and malignancies during anti-TNF therapy in IBD patients affect all age groups – results from a 13-yr real-world retrospective study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Majumder, S.(1,2);Melanie , L.(2);Joanne , D.(2);Naveen, S.(2);Quraishi, M.N.(2);Cooney, R.(2);Ghosh, S.(3);Iacucci, M.(1,2,4);N Shivaji, U.(1,2,4)*;
Created: Friday, 14 July 2023, 11:05 AM
P475: Profiling the use of Complementary Alternative Medicines among IBD patients
Year: 2022
Source: ECCO'22
Authors: Sudhakar, P.(1);Stiers, R.(1);Dycker, E.D.(2);Geens, P.(2);Paps, A.(2);Lambrechts, T.(2);Keersmaekers, B.(2);Sabino, J.(1,3);Ferrante, M.(1,3);Vermeire, S.(1,3);Verstockt, B.(1,3);
Created: Friday, 11 February 2022, 3:52 PM
P475: Rapid point-of-care anti-drug antibodies measurement correlates with standardised T tests and facilitate a proactive therapeutic drug monitoring approach in IBD patients on anti-TNF-α maintenance therapy
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Facchin*1, A. Buda2, R. Cardin1, R. D'Incà3, F. Zingone3, N. Agbariah1, E. Savarino3

Created: Friday, 22 February 2019, 9:41 AM
P475: Real world data on treatment success and drug persistence in anti-TNF therapy for ulcerative colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Lundekvam, J.A.(1);Høivik, M.L.(1);Anisdahl, K.(1);Moum, B.(1);Medhus, A.W.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P475: Switching from infliximab originator to CT-P13 is not related to increased immunogenicity in IBD patients: a prospective case-control study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Fiorino G.*1, Radice S.1, Gilardi D.1, Correale C.1, Allocca M.1, Furfaro F.1, Alfieri M.1, Nagore D.2, Del Rio L.2, Pascual J.2, Martínez A.2, Danese S.1,3

Created: Wednesday, 20 February 2019, 10:36 AM
P476 Efficacy and safety of 2 vedolizumab IV regimens in patients with perianal fistulising Crohn’s disease: results of the ENTERPRISE study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D. Schwartz1, L. Peyrin-Biroulet2, K. Lasch3, S. Adsul4, S. Danese5

Created: Thursday, 30 January 2020, 10:12 AM
P476: Characterization of cardiac conduction abnormalities reported in the phase 3 ELEVATE programme
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Vermeire, S.(1)*;Yarur, A.(2);Rubin, D.T.(3);Dubinsky, M.C.(4);Regueiro, M.(5);Irving, P.(6,7);Peyrin-Biroulet, L.(8,9);Goetsch, M.(10);Gu, G.(11);Wu, J.(12);Modesto, I.(13);McDonnell, A.(14);Rabbat, C.J.(15);Green, J.(16);Anthopoulos, P.(17);
Created: Friday, 14 July 2023, 11:05 AM
P476: Combined therapy with adalimumab and mesenchymal stromal cells contributes to reduction in the degree of inflammation in ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

O. Knyazev1, A. Kagramanova1, D. Kulakov*1, M. Zvyaglova1, A. Parfenov1

Created: Friday, 22 February 2019, 9:41 AM
P476: Disease recurrence patterns in patients undergoing bowel resections for Crohn’s disease.
Year: 2022
Source: ECCO'22
Authors: Ahmed, M.(1);Chacko, J.(1);Zimerly, S.(1);Patel, A.(1);
Created: Friday, 11 February 2022, 3:52 PM
P476: Effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from the ENEIDA registry
Year: 2021
Source: ECCO'21 Virtual
Authors: Chaparro, M.(1);Garre, A.(1);Iborra, M.(2);Sierra, M.(3);Barreiro-de Acosta, M.(4);Fernández-Clotet, A.(5);de Castro, L.(6);Boscá-Watts, M.(7);Casanova, M.J.(1);López-García, A.(8);Lorente, R.(9);Rodríguez, C.(10);Carbajo, A.Y.(11);Arroyo, M.T.(12);Gutiérrez, A.(13);Hinojosa, J.(14);Martínez-Pérez, T.(15);Villoria, A.(16);Bermejo, F.(17);Busquets, D.(18);Camps, B.(19);Cañete, F.(20);Manceñido, N.(21);Monfort, D.(22);Navarro-Llavat, M.(23);Pérez-Calle, J.L.(24);Ramos, L.(25);Rivero, M.(26);Angueira, T.(27);Camo, P.(28);Carpio, D.(29);García-de-la-Filia, I.(30);González-Muñoza, C.(31);Hernández, L.(32);Huguet, J.M.(33);Morales, V.J.(34);Sicilia, B.(35);Vega, P.(36);Domènech, E.(20);Gisbert, J.P.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P476: Fermentable carbohydrates (FODMAPs) as triggers of functional gastrointestinal symptoms in patients with quiescent inflammatory bowel disease: a double-blind, placebo-controlled, randomised, cross-over re-challenge trial
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Cox*1, A. Prince1, 2, C. Myers1, 3, P. M. Irving1, 4, J. O. Lindsay5, M. C. Lomer1, 4, K. Whelan1

Created: Friday, 22 February 2019, 9:49 AM
P476: Sigmoidostomy or Hartman's procedure during laparoscopic subtotal colectomy for acute colitis complicating inflammatory bowel disease? A comparative study in 129 consecutive patients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Mege D.*1, Buskens C.2, Maggiori L.1, Stellingwerf M.2, Bemelman W.2, Panis Y.1

Created: Wednesday, 20 February 2019, 10:36 AM
P476: Using small bowel and colon video capsule endoscopy to optimise Crohn’s disease therapy may improve patient quality of life
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Saunders1*, M. Blüher1, R. Torrejon Torres1, M.J. Williams2, K. Richardson2, L. Kosinski3

Created: Thursday, 21 February 2019, 9:14 AM
P477 Italian real-life study evaluating the long-term effectiveness of vedolizumab for the treatment of inflammatory bowel disease: the elderly cohort
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D. Pugliese, G. Privitera, A. Armuzzi, LIVE IG-IBD study group (Ambrogio Orlando and Federica Crispino – AZ.Osp. Ospedali Riuniti ‘Villa Sofia-Cervello’ Palermo Nicolò Mezzina and Alessandro Massari – ASST Fatebenefratelli Sacco Department of Biochemical and Clinical Sciences University of Milan Milan Lucienne Pellegrini and Fabiana Castiglione – AOU ‘Federico II’ Napoli Lucrezia Laterza and Franco Scaldaferri – CEMAD Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Anna Viola and Walter Fries – Policlinico Messina Pietro Soru and Flavio Caprioli – Fondazione IRCCS Cà Granda Ospedale Policlinico Milan Maria Cappello and Barbara Scrivo – Universita’ di Palermo Policlinico Paolo Giaccone Palermo Brigida Barberio and Edoardo Savarino – University of Padua - Azienza Ospedaliera di Padova Padova Chiara Ricci – Università degli Studi di Brescia Ospedali Civili Brescia Brescia Dario Pluchino – AOU Policlinico Vittorio Emanuele Catania Maria Lia Scribano – San Camillo-Forlanini Rome Lorenzo Bertani Azienda Ospedaliera Universitaria Pisana Pisa Renato Sablich – Azienda per l’Assistenza Sanitaria n. 5 ‘Friuli Occidentale’ Pordenone Luca Pastorelli – University of Milan IRCCS Policlinico San Donato Milan Francesco Manguso – AORN A. Cardarelli Napoli Angela Variola – IRCCS Sacro Cuore Don Calabria Negrar di Valpolicella (VR) Antonio Di Sario – Università Politecnica delle Marche Ospedali Riuniti - University Hospital Ancona Laurino Grossi – G d’Annunzio University Ospedale Spirito Santo Pescara Davide Giuseppe Ribaldone – University of Turin Turin Giuseppe Biscaglia – IRCCS Ospedale Casa Sollievo della Sofferenza San Giovanni Rotondo (FG) Pierenrico Lecis – Ospedale S.Maria del Prato - ULSS 1 Dolomiti Belluno Paola Balestrieri – Unviersità Campus Biomedico Roma Gianmarco Mocci – AOU G Brotzu Cagliari Angelo Viscido – University of L’Aquila L’Aquila Maria Carla Di Paolo Azienda Ospedaliera San Giovanni Addolorata Roma Sara Onali – University of Rome Tor Vergata Rome Stefano Rodinò – Azienda Ospedaliera ‘Pugliese-Ciaccio’ Catanzaro Marina Coletta – ASST Santi Paolo e Carlo-Ospedale San Paolo Polo Universitario Milano Mariabeatrice Principi – Azienda Ospedaliera Universitaria Policlinico di Bari Bari Agnese Miranda – Università della Campania Luigi Vanvitelli II Policlinico di Napoli Napoli Arnaldo Amato – Valduce hospital Como Cristina Bezzio – Rho Hospital ASST Rhodense Rho Carlo Petruzzellis – Istituto Ospedaliero Fondazione Poliambulanza Brescia Silvia Mazzuoli – Osp San Nicola Pellegrino ASL BT Trani Stefano Festa – San Filippo Neri Hospital Rome Alessandro Sartini – Azienda Ospedaliero-Universitaria Policlinico di Modena Modena Libera Frangiulo – Ospedale SS. Annunziata di Taranto Taranto Sara Gallina – Ospedale Belcolle Viterbo Giorgia Bodini – University of Genoa Genoa)

Created: Thursday, 30 January 2020, 10:12 AM
P477: Assessment of treatment sequence and real-world outcomes in patients with Ulcerative Colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Chen, J.(1);Zhao, Y.(1);Liu, T.(1);Candela, N.(2);Lasch, K.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P477: Clinical remission by legacy vs. FDA definitions: definition justification and results from UNIFI Study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

W. J. Sandborn*1, R. Strauss2, H. Zhang2, J. Johanns2, P. Szapary2, C. Marano2, S. Danese3

Created: Friday, 22 February 2019, 9:41 AM
P477: Effect of tumour necrosis factor antagonists on avoiding surgery in stricturing Crohn’s disease: a tertiary centre real-life experience
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Allocca*1, G. Fiorino1, C. Bonifacio2, A. Spinelli3, A. Repici4, A. Malesci5, 6, L. Balzarini2, S. Danese1, 7

Created: Friday, 22 February 2019, 9:49 AM
P477: Patient satisfaction and cost saving analysis of telemedicine in patients with inflammatory bowel disease.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Bossa, F.(1)*;Carparelli, S.(1);Guerra, M.(1);Cocomazzi, F.(1);Martino, G.(1);Annese, M.(1);Nardella, M.(1);Bellucci, N.(2);Gagliardi, R.(3);Terracciano, F.(1);Pacilli, L.(4);Perri, F.(1);
Created: Friday, 14 July 2023, 11:05 AM